These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 2652596)

  • 1. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
    Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
    [No Abstract]   [Full Text] [Related]  

  • 2. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
    Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal transplantation from living donors mismatched for two HLA haplotypes.
    Sødal G; Albrechtsen D; Berg KJ; Bondevik H; Brekke IB; Fauchald P; Jakobsen A; Talseth T; Thorsby E; Flatmark A
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1509-10. PubMed ID: 3079022
    [No Abstract]   [Full Text] [Related]  

  • 4. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
    Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Related donor kidney transplantation is the best form of treatment for uremia.
    Groth CG; Fehrman I; Ringdén O; Lundgren G
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
    [No Abstract]   [Full Text] [Related]  

  • 6. Early rejection following donor-specific transfusion prior to HLA-mismatched living related renal transplantation.
    Sells RA; Scott MH; Prieto M; Bone JM; Evans GM; Millar R; Hills AN
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1173-4. PubMed ID: 2650088
    [No Abstract]   [Full Text] [Related]  

  • 7. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of donor-specific transfusions on renal transplantation in children.
    Potter D; Garovoy M; Hopper S; Terasaki P; Salvatierra O
    Pediatrics; 1985 Sep; 76(3):402-5. PubMed ID: 3162150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in donor-specific cell-mediated lympholysis (CML) response associated with success of early steroid withdrawal in DST-azathioprine-treated renal transplant recipients.
    Burlingham WJ; Grailer A; Sollinger HW
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1818-9. PubMed ID: 2523595
    [No Abstract]   [Full Text] [Related]  

  • 10. Three year experience of donor specific transfusion and concomitant cyclosporine A.
    Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
    [No Abstract]   [Full Text] [Related]  

  • 11. Living related donor renal transplantation in Semarang, Indonesia (1985 to 1991).
    Shofa C; Soewito A; Darmono E; Hendro W; Lysiani S; Purwanto ; Chandra M; Faik H; Rifki M; Parsudi AI
    Transplant Proc; 1992 Oct; 24(5):1813. PubMed ID: 1412858
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal.
    Reed A; Pirsch JD; Armbrust MJ; Burlingham WJ; Knechtle SJ; D'Alessandro AM; Sollinger HW; Kalayoglu M; Belzer FO
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1321-2. PubMed ID: 1989226
    [No Abstract]   [Full Text] [Related]  

  • 13. Donor-specific and random transfusions in HLA-haploidentical kidney transplantation.
    Garcia LF; Arango AM; Rezonzew R; Correa M; Angel B; Guzman B; Paris SC; Arbelaez M; Henao JE; Mejia G
    Transplant Proc; 1991 Apr; 23(2):1744-6. PubMed ID: 2053141
    [No Abstract]   [Full Text] [Related]  

  • 14. Cadaver renal transplantation without maintenance steroids.
    Johnson RW; Mallick NP; Bakran A; Pearson RC; Scott PD; Dyer P; Donaghue D; Morris D; Gokal R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1581-2. PubMed ID: 2652513
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled trial of triple therapy in renal transplantation.
    Salaman JR; Griffin PJ; Ross WB; Williams JD
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1935-6. PubMed ID: 3079061
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term results of controlled cyclosporine conversion at 3 months after renal transplantation.
    Kootte AM; van Dorp WT; van Bockel JH; van Es LA; Paul LC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1585-6. PubMed ID: 2652515
    [No Abstract]   [Full Text] [Related]  

  • 17. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
    Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
    [No Abstract]   [Full Text] [Related]  

  • 18. Donor specific blood transfusions do not improve graft survival in living related donor transplantation.
    Garcia VD; Kraemer ES; Prompt CA; Santos A; Caovila J; Duarte A; Filho AN; Goldani JC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507
    [No Abstract]   [Full Text] [Related]  

  • 19. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of cyclosporine in renal transplantation from HLA haploidentical living donors: no benefit of transfusion or additional azathioprine.
    Albrechtsen D; Flatmark A; Leivestad T; Brynger H; Frødin L; Groth CG; Lundgren G; Persson N
    Transplant Proc; 1990 Feb; 22(1):214-5. PubMed ID: 2408207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.